Search results
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters· 1 day ago, opens new tab will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators accept the shot it has started manufacturing that targets a variant ...
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 4 days agoThe COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs that tried to...
Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots
Barrons.com· 5 days agoAfter disappointing sales for their Covid vaccines last year, Moderna, Novavax, and Pfizer are...
Penn researchers made an avian flu vaccine using a technique that created COVID vaccines
Philly.com· 3 days agoUniversity of Pennsylvania researchers have developed an mRNA vaccine for the H5N1 avian flu drawing...
Vaccine makers receive stock boost after third human bird flu case in US
Newsweek· 3 days agoShares in some companies that produce vaccines have seen stock boosts following a small number of...
Why Vaccine Stocks Rallied This Week | The Motley Fool
The Motley Fool· 2 days agoShares of vaccine stocks Moderna (MRNA 1.58%), Novavax (NVAX 2.31%), and BioNTech SE (BNTX -2.07%)...
3 Things You Need to Know If You Buy Novavax Today | The Motley Fool
The Motley Fool· 4 days agoNovavax (NVAX 5.30%) stock has both soared and plummeted at times in recent years. Investors...
Free COVID-19 vaccines could be a thing of the past as federal program is set to expire early
Chicago Sun-Times· 3 days agoWhen COVID-19 vaccines entered the commercial market, the federal government introduced a program to...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
AOL· 1 day agoNovavax's updated vaccine targets a variant called JN.1, which is in line with European recommendations. The European Union's regulator told vaccine makers ...